Takakazu Kawase
Toyoake, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
High-Risk Human Leukocyte Antigen Mismatch Combinations Responsible for Severe Acute Graft-Versus-Host Disease in Cord Blood Transplantation.
Journal: Transplantation and cellular therapy
Published: May 20, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD Prophylaxes.
Journal: Transplantation
Published: February 14, 2025
Development of off-the-shelf universal T cell therapies from ES/iPS cells: applications in cancer and viral infection
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 02, 2024
Hepatitis B virus-specific human stem cell memory T cells differentiate into cytotoxic T cells and eradicate HBV-infected hepatocytes in mice.
Journal: FEBS letters
Published: December 03, 2023
Peripheral T cell profiling reveals downregulated exhaustion marker and increased diversity in lymphedema post-lymphatic venous anastomosis.
Journal: iScience
Published: March 08, 2023
Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness of whole-body MRI-derived indices.
Journal: PloS one
Published: November 15, 2022
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.
Journal: Nagoya journal of medical science
Published: July 13, 2022
Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation.
Journal: Transplantation and cellular therapy
Published: January 27, 2022
Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation.
Journal: Bone marrow transplantation
Published: February 28, 2021
Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis.
Journal: Hematology (Amsterdam, Netherlands)
Published: February 17, 2021
Last Updated: 09/26/2026